Skip Navigation

Cardiovascular Research 2002 54(2):361-379; doi:10.1016/S0008-6363(02)00273-0
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kostin, S.
Right arrow Articles by Schaper, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kostin, S.
Right arrow Articles by Schaper, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Structural correlate of atrial fibrillation in human patients

Sawa Kostina,*, Gabi Kleina, Zoltan Szalayb, Stefan Heinb, Erwin P Bauerb and Jutta Schapera

aDepartment of Experimental Cardiology, Max-Planck Institute, Benekestrasse 2, D-61231 Bad Nauheim, Germany
bDepartment of Cardiac Surgery, Kerckhoff Clinic, Bad Nauheim, Germany

* Corresponding author. Tel.: +49-6032-705-402; fax: +49-6032-705-419 skostin{at}kerckhoff.mpg.de

Objective: We tested the hypothesis that structural remodeling of cellular connections, alterations in the expression of connexins (Cx), and an increase in fibrosis represent anatomic substrates of atrial fibrillation (AF). Methods: In 31 patients with AF undergoing a Maze procedure and 22 patients in sinus rhythm (SR), biopsies were taken intraoperatively from the right atrial (RA) free wall and appendages and investigated with immunoconfocal and electron microscopy. Results: All patients with AF exhibited a concomitant lateralization of gap junctional proteins Cx43 and Cx40, and N-cadherin (the major mechanical junction protein), instead of being confined to the intercalated discs, as observed in SR. These results were confirmed by quantitative immunoconfocal analysis and electron microscopy. Among diverse junctional proteins, in AF, Cx40 was markedly heterogenous in distribution. As compared with the SR group, Cx43 was significantly decreased in AF by 57% in RA appendages and by 56% in RA free wall. Cx40 was reduced by 54% in appendages, but had a tendency to be increased in the RA free wall. Collagen I was significantly higher in AF than in SR by 48% in RA appendages and by 69% in the RA free wall tissues. Conclusions: The structural correlate of AF comprises extensive concomitant remodeling of mechanical and electrical junctions, reduction of Cx43, heterogenous distribution of Cx40 in terms of different amounts of Cx40 in different RA tissues or in spatially adjacent regions of atrial myocardium. These changes, together with augmentation of fibrosis, may underlie localized conduction abnormalities and contribute to initiation and self-perpetuation of re-entry pathways and AF.

KEYWORDS Arrhythmia (mechanisms); Gap junctions; Remodeling; Fibrosis; Supraventr. arrhythmia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
N. J. Severs, A. F. Bruce, E. Dupont, and S. Rothery
Remodelling of gap junctions and connexin expression in diseased myocardium
Cardiovasc Res, October 1, 2008; 80(1): 9 - 19.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. M. Kallergis, E. G. Manios, E. M. Kanoupakis, H. E. Mavrakis, D. A. Arfanakis, N. E. Maliaraki, C. E. Lathourakis, G. I. Chlouverakis, and P. E. Vardas
Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation biochemical assessment of collagen type-I turnover.
J. Am. Coll. Cardiol., July 15, 2008; 52(3): 211 - 215.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
I. Savelieva and J. Camm
Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches
Europace, June 1, 2008; 10(6): 647 - 665.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. I. Skalidis, M. I. Hamilos, I. K. Karalis, G. Chlouverakis, G. E. Kochiadakis, and P. E. Vardas
Isolated Atrial Microvascular Dysfunction in Patients With Lone Recurrent Atrial Fibrillation
J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2053 - 2057.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.